Status:
TERMINATED
Protocol for Radiofrequency Ablation of Pulmonary Neoplasms
Lead Sponsor:
Oncology Specialties, Alabama
Conditions:
Pulmonary Neoplasms
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This research trial involves the development of a new treatment for lung tumors. It is for patients whose tumor cannot be surgically removed, have refused surgery, or the tumor has not responded well ...
Eligibility Criteria
Inclusion
- The patients enrolled in this study should be judged to have sufficient survival to benefit from control of local disease and include at least one of the following:
- unresectable primary or metastatic lung tumors
- may benefit from multiple modalities of therapy
- chemotherapeutic or radiation oncologic options have been exhausted
Exclusion
- 1\. co-existing morbidities that preclude the use of surgery
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00232128
Start Date
June 1 2003
Last Update
January 12 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Comprehensive Cancer Institute
Huntsville, Alabama, United States, 35801